Skip to main content
Donald Lannin, MD, General Surgery, New Haven, CT

DonaldRoweLanninMD

General Surgery New Haven, CT

Breast, Surgical Oncology (Other than Breast)

Professor of Surgery, Yale University

Dr. Lannin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lannin's full profile

Already have an account?

  • Office

    800 Howard Ave Lowr Level
    Yale Physicians Building
    New Haven, CT 06519
    Phone+1 203-785-3577
    Fax+1 203-737-4033

Education & Training

  • University of Minnesota
    University of MinnesotaResidency, Surgery, 1974 - 1982
  • University of Minnesota Medical School
    University of Minnesota Medical SchoolClass of 1974

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2002 - 2025
  • NC State Medical License
    NC State Medical License 1982 - 2012
  • MN State Medical License
    MN State Medical License 1976 - 2005
  • American Board of Surgery Surgery

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2010-2014
  • Top Doctors: New York Metro Area Castle Connolly, 2010-2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • Do All Positive Margins in Breast Cancer Patients Undergoing a Partial Mastectomy Need to Be Resected?March 2018

Press Mentions

  • Connecticut's Top Doctors 2021: Over 1,500 Physicians in 66 Specialties
    Connecticut's Top Doctors 2021: Over 1,500 Physicians in 66 SpecialtiesJune 1st, 2021
  • Neoadjuvant Durvalumab plus Weekly Nab-Paclitaxel and Dose-Dense doxorubicin/cyclophosphamide in Triple-Negative Breast Cancer
    Neoadjuvant Durvalumab plus Weekly Nab-Paclitaxel and Dose-Dense doxorubicin/cyclophosphamide in Triple-Negative Breast CancerFebruary 8th, 2021
  • Yale Study: Breast Cancer Found Earlier in States with Expanded Medicaid
    Yale Study: Breast Cancer Found Earlier in States with Expanded MedicaidJuly 1st, 2020
  • Join now to see all

Professional Memberships